Watching changes in walking for muscle and nerve diseases
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study watches how people with certain muscle or nerve diseases walk over time. It may help doctors understand changes in walking patterns and is open to adults who can walk and have a genetic diagnosis of a neuromuscular condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a genetic diagnosis of a muscle disease (like muscular dystrophy, myopathy), spinal muscular atrophy, or Charcot-Marie-Tooth type 1 or 2
- You are able to walk, even if you need a walker, cane, or help from another person
- You do not have a heart condition that moderately limits your daily activities (dilated or ischemic heart disease)
- You do not have severe breathing weakness (lung function is above 40% and oxygen levels are stable during sleep)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a portable device that analyzes walking without markers. It aims to see if it can help assess walking in people with neuromuscular diseases and healthy volunteers, which could lead to simpler check-ups.
This study uses wearable devices (like smartwatches or activity trackers) to monitor movement and motor development in young children with spinal muscular atrophy (SMA), a rare genetic condition affecting muscle strength. The goal is to see if wearables can track disease progression and treatment response better than traditional clinic visits.
This study tests if using assistive walking devices, after a short training period, can lower the risk of falls in people with neuromuscular diseases. It aims to help you stay steady and safe on your feet.
This study looks at how Charcot-Marie-Tooth disease (CMT) or related inherited nerve conditions change over time. It may help researchers better understand what to expect and guide future treatments.
This study observes how spinal muscular atrophy changes over time without giving an investigational treatment. It may help researchers learn what to expect in the disease and improve future care.
This study looks at how children and teens with Duchenne muscular dystrophy (DMD) or spinal muscular atrophy (SMA) walk, by having them do walking tests while wearing sensors. The goal is to find better ways to track how these diseases progress and how treatments work over time, without needing blood tests or scans.
Hear when a new Charcot-Marie-Tooth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.